Target intelligence / Profile preview

Survival of motor neuron 2 pre-mRNA intronic splicing silencer N1 (ISS-N1)

Target
ISS-N1
Molecular classification
RNA, Pre-mRNA element, Intronic splicing silencer
01

Overview

The Survival of motor neuron 2 (SMN2) pre-mRNA intronic splicing silencer N1 (ISS-N1) is a 15-nucleotide regulatory sequence located in intron 7 of the SMN2 gene [1.1.1]. In patients with spinal muscular atrophy (SMA), the loss of the SMN1 gene makes them dependent on the nearly identical SMN2 gene; however, a single nucleotide difference in SMN2 leads to the frequent skipping of exon 7, resulting in a truncated and unstable SMN protein [1.1.4, 1.2.1]. ISS-N1 acts as a potent inhibitory element that recruits negative splicing factors, such as heterogeneous nuclear ribonucleoproteins (hnRNP A1 and A2), to suppress exon 7 inclusion [1.2.1, 1.2.4]. Therapeutic intervention using antisense oligonucleotides, such as Nusinersen, specifically targets and masks the ISS-N1 sequence [1.2.5]. This masking prevents the binding of repressor proteins, effectively promoting the inclusion of exon 7 during pre-mRNA splicing [1.2.1, 1.2.5]. Consequently, this increases the production of full-length, functional SMN protein, which is essential for the survival and maintenance of motor neurons [1.1.4, 1.4.3].

Other names
Intronic splicing silencer N1SMN2 intron 7 ISS-N1SMN2 ISS-N1SMN2 intronic splicing silencer N1
02

Mechanism of action

Antisense oligonucleotide binding to the ISS-N1 site prevents the recruitment of splicing repressor proteins such as hnRNP A1 and A2, thereby promoting the inclusion of exon 7 in the SMN2 transcript and increasing the production of functional SMN protein.

03

Biological functions

RNA splicing regulationExon inclusionSplicing inhibition
04

Disease associations

Spinal muscular atrophy
05

Safety considerations

Intrathecal administration complicationsPotential renal toxicityCoagulation abnormalities (thrombocytopenia)
06

Interacting drugs

Nusinersen
07

Biomarkers

SMN protein levelsSMN2 full-length mRNA levelsNeurofilament light chain (NfL)Phosphorylated neurofilament heavy chain (pNF-H)

Beyond the preview

Go deeper on Survival of motor neuron 2 pre-mRNA intronic splicing silencer N1 (ISS-N1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Survival of motor neuron 2 pre-mRNA intronic splicing silencer N1 (ISS-N1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call